| Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel | European Heart Journal | 2017 | 1.3K |
| Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study) | Circulation | 2017 | 182 |
| Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial | Drug Research | 2017 | 160 |
| Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals | Transfusion | 2017 | 159 |
| Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study | Lancet Diabetes and Endocrinology,the | 2017 | 148 |
| Postoperative pain-from mechanisms to treatment | Pain Reports | 2017 | 133 |
| Optimizing Cholesterol Treatment in Patients With Muscle Complaints | Journal of the American College of Cardiology | 2017 | 133 |
| Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity | Pharmacological Research | 2017 | 123 |
| Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program) | American Journal of Cardiology | 2017 | 98 |
| Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2 | Journal of Hypertension | 2017 | 97 |
| Personal model-assisted identification of NAD and glutathione metabolism as intervention target in NAFLD | Molecular Systems Biology | 2017 | 92 |
| Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study | Journals of Gerontology - Series A Biological Sciences and Medical Sciences | 2017 | 92 |
| Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up | Circulation | 2017 | 92 |
| The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents | Pain Reports | 2017 | 87 |
| Depression as a modifiable factor to decrease the risk of dementia | Translational Psychiatry | 2017 | 84 |
| The cardiovascular health benefits of apples: Whole fruit vs. isolated compounds | Trends in Food Science and Technology | 2017 | 83 |
| Safety of Perioperative Glucocorticoids in Elective Noncardiac Surgery: A Systematic Review and Meta-analysis | Anesthesiology | 2017 | 83 |
| Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs | Journal of Clinical Lipidology | 2017 | 80 |
| Regulation of PCSK9 by nutraceuticals | Pharmacological Research | 2017 | 68 |
| Effects of pomegranate juice on blood pressure: A systematic review and meta-analysis of randomized controlled trials | Pharmacological Research | 2017 | 68 |
| Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism | Circulation | 2017 | 63 |
| Exosomes: Nanoparticulate tools for RNA interference and drug delivery | Journal of Cellular Physiology | 2017 | 62 |
| Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial | International Journal of Antimicrobial Agents | 2017 | 56 |
| Changing epidemiology of candidaemia in Australia | Journal of Antimicrobial Chemotherapy | 2017 | 56 |
| Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease | Fìtoterapìâ | 2017 | 54 |
